Bristol-Myers Squibb Co vs Dollar General Corp. — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while Dollar General Corp. trades at $120.29 (market cap $26.49B). The key difference: Bristol-Myers Squibb Co is far larger — about 4.9× Dollar General Corp.'s market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | DG | |
|---|---|---|
Market Cap | $129.94B | $26.49B |
Sector | Health | Consumer Staples |
52-Week High | $65.89 | $156.26 |
52-Week Low | $42.60 | $95.94 |
Enterprise Value | $163.92B | $40.93B |
Dividend Yield | 3.96% | 1.97% |
Trailing returns across standard periods
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.
Read more on DG →